BSL-3 lab at National Institute of Virology Kerala unit in Alappuzha ready, awaits certification
Officials said the laboratory would be made operational after it receives certification from the Department of Biotechnology under the Union government. Once functional, the facility will enable Nipah virus testing and final confirmation within the State. Currently, samples should be sent to NIV Pune for final confirmation.
'The BSL-3 lab will become operational soon. The trial run commenced three weeks ago and will continue for three months. Once the trial is complete, we will apply for certification from the Department of Biotechnology. After certification, the lab will be able to conduct diagnostic testing and research for various viral diseases, including Nipah. It can also conduct diagnostics, but not research, on Risk Group 4 pathogens,' said an official.
The National Centre for Disease Control (NCDC) classifies laboratories into different categories from BSL 1 to 4 based on a combination of laboratory practices, safety equipment, and facilities. A BSL-3 lab is a high-containment facility intended for the testing and research of highly pathogenic and infectious agents. These labs include specialised safety systems and engineering controls.
The NIV Kerala unit, functioning under the Indian Council of Medical Research (ICMR), was initially established as a BSL-2 facility in February 2008. It operated with limited infrastructure at the Government Medical College Hospital, Alappuzha, until late 2022, when it was relocated to a newly constructed permanent facility in Kuravanthodu. Prime Minister Narendra Modi virtually inaugurated the new facility in Februray 2024.
At present, the unit undertakes research on various locally prevalent viral diseases, focusing on epidemiological, virological, immunological, entomological and socio-behavioural aspects.
Notably, the NIV Kerala unit was among the first four laboratories in India, apart from NIV Pune, the apex institution, to be designated as a State nodal laboratory for COVID-19 testing at the onset of the pandemic.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
30 minutes ago
- Time of India
Construction resumes on 100-bed critical care block at Ambala cantonment civil hospital: Anil Vij
AMBALA: Haryana's energy, transport and labour minister, Anil Vij, announced on Friday that construction work on a new 100-bedded building at the Ambala Cantonment Civil Hospital has resumed. Once completed, the hospital's capacity will double from 100 to 200 beds, significantly enhancing healthcare services for the region. Designed as a state-of-the-art Critical Care Unit (CCU), the new seven-storey block will be equipped with modern medical infrastructure aimed at providing advanced and emergency care. The facility will focus on infection control, ensuring the safety of regular patients while offering dedicated treatment zones for critical and infectious cases. Anil Vij shared that construction had previously stalled due to a pending case in the High Court and subsequent arbitration proceedings. With the legal matters now resolved and re-tendering completed, the project has resumed with a sanctioned cost of Rs 14.79 crore. The hospital includes two basement levels, one for vehicle parking and other for centralized air-conditioning and gas plants. Ground floor includes a registration-cum-reception area, emergency services, and public amenities. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Is it legal? How to get Internet without paying a subscription? Techno Mag Learn More Undo First floor has a dedicated 28-bed emergency ward. Second floor has an Infectious Disease Intensive Care Unit (ICU). The third and fourth floors areequipped with Operation Theatres, Super Specialty OTs, patient wards, and a high-dependency Critical Care Unit (CCU). Highlighting the importance of the project, Anil Vij said, 'With the ever-growing number of patients, bed shortage has become a challenge. This new wing will not only address capacity issues but also raise the standard of care, particularly for emergency and infectious cases.' The CCU will feature advanced monitoring systems to track vital signs like heart rate and blood pressure, along with life-saving support including oxygen therapy, emergency interventions, and post-operative care. Specialized wards for Covid-19 and infectious diseases will also be part of the facility. This expansion marks a step forward in strengthening critical care infrastructure in Ambala Cantonment and neighbouring areas.
The Hindu
5 hours ago
- The Hindu
Nipah virus and Kerala: What is the connection?
Nipah virus is not new to Kerala: the State is experiencing it's eighth outbreak since 2018 this July. So far, there have been four confirmed cases: of these, two persons have died, while the other two remain hospitalised. A total of 675 people across the State are currently under observation, with 38 classified as being in the highest risk question that many have wondered about is: why Kerala? Why is it that this one State has seen multiple outbreaks of the deadly virus? What do we know about how it spills over from fruit bats to humans? And what can be done to contain it? Guest: Dr. Anoop Kumar A.S., director of critical care medicine at Aster North Kerala Cluster, who played a pivotal role in detecting the Nipah virus outbreak in the State in 2018 Host: Zubeda Hamid Edited by Sharmada Venkatasubramanian Listen to more In Focus podcasts:
&w=3840&q=100)
First Post
10 hours ago
- First Post
War against cancer: A victory in progress as death rates tumble with new drugs, screening and prevention
The chances of getting affected by cancer increase as people age. Since the 1990s, the age-adjusted death rate related to cancer has fallen considerably read more The fight against cancer has been yielding results slowly and steadily. Data on cancer's manifestations and treatment has painted a positive picture. Could that mean that the world is inching closer to a cure? While an answer to that remains uncertain, other factors, like death rates and advanced medical treatment, suggest that things are looking better than they were a decade ago. Here's how: Falling death rates The chances of getting affected by cancer increase as people age. Since the 1990s, the age-adjusted death rate related to cancer has fallen considerably. For example, in the US, where cancer is the second-most common cause of death, the age-adjusted death rate is now a third lower than in the 1990s. This trend is not exclusive to America, but is mimicked by other developed countries as well. A 2024 report by the Nation on the Status of Cancer shows that overall death rates from cancer declined steadily among both men and women from 2001 through 2022, even during the first two years of the Covid-19 pandemic. STORY CONTINUES BELOW THIS AD Childhood leukaemia survival rates go up The survival rate of childhood leukaemia has increased significantly in the past few years. Now, it has a five-year survival rate above 90 per cent. This has been made possible by advancements in treatment measures for Acute Lymphoblastic Leukaemia (ALL), which is the most common type that affects children. Better prevention One of the most overlooked success stories in the fight against cancer is prevention. For instance, smoking rates have dropped sharply in high-income countries, likely preventing over 3 million cancer deaths in the US alone since 1975. Yet smoking still accounts for one in five cancer deaths globally. This means that anti-tobacco efforts in low- and middle-income countries, where smoking remains widespread, have the potential to save millions more lives. Cheaper treatment Cancer treatment has gone easy on the pockets considerably. Curbing the spread of cervical cancer, the most common cancer among women, is a case in point. Cervical cancer is caused by the delayed side-effect of infection with the human papillomavirus (HPV). Now, the prevalence of the HPV vaccine and its administration to young girls across the world has brought down the chances of getting the bug at all. In the UK, for example, HPV vaccines have brought down the rates of cervical cancer among women in their 20s are down by 90 per cent.
